According to a market research study prepared by GlobalData, in 2009 DePuy held a 21% market share of the global hip and knee replacement market. This leads to the conclusion that as many 1 in 5 hip implant recipients have had DePuy devices installed and are now subject to the recall.

The recall involves more than 93,000 units that had been sold since 2003. It is reported that Johnson & Johnson earned 5.4 billion dollars from the sales of the product. Studies have shown that an alarming number of patients who had received DePuy’s ASR total hip replacement have needed to have surgery to repair the devices. Because of the devices "metal-on-metal" design, the hip implants can shed particles into the patient causing serious, painful reactions, often leading to further surgery.

DePuy reportedly does not keep a list of patients who received the defective implant. Thus no notification has been sent by the manufacturer to those who are now subject to the recall. Some physicians have taken the affirmative step of notifying their patients who now have the device. Alarmingly most patients remain unaware.

`

DrugSettlement.com is advising anyone who has had a hip implant since 2003 to do the following:

1. Contact the doctor who performed the hip replacement to determine whether or not whether you received a DePuy ASR XL Acetabular System for Total Hip Repalcement or ASR resurfacing device;
2. Follow your doctor's instructions;
3. Contact Drugsettlement.com to preserve your rights to be compensated.